4//SEC Filing
KANE JOHN C 4
Accession 0001204391-07-000023
CIK 0001004960other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 8:31 PM ET
Size
21.5 KB
Accession
0001204391-07-000023
Insider Transaction Report
Form 4
CONNETICS CORPCNCT
KANE JOHN C
Director
Transactions
- Disposition to Issuer
Option to Purchase Common Stock
2006-12-29$10.38/sh−30,000$311,250→ 0 totalExercise: $7.13From: 2006-12-29Exp: 2007-03-25→ Common Stock (30,000 underlying) - Disposition to Issuer
Common Stock, Par Value $0.001
2006-12-29$17.50/sh−7,500$131,250→ 0 total - Disposition to Issuer
Option to Purchase Common Stock
2006-12-29$13.00/sh−7,500$97,500→ 0 totalExercise: $4.50From: 2006-12-29Exp: 2008-05-22→ Common Stock (7,500 underlying) - Disposition to Issuer
Option to Purchase Common Stock
2006-12-29$11.33/sh−10,000$113,300→ 0 totalExercise: $6.17From: 2006-12-29Exp: 2011-05-17→ Common Stock (10,000 underlying) - Disposition to Issuer
Option to Purchase Common Stock
2006-12-29$6.57/sh−15,000$98,550→ 0 totalExercise: $12.80From: 2006-12-29Exp: 2012-05-16→ Common Stock (15,000 underlying) - Disposition to Issuer
Common Stock, Par Value $0.001
2006-12-29$17.50/sh−27,439$480,183→ 0 total
Footnotes (5)
- [F1]In connection with the merger agreement between issuer and Stiefel Laboratories, shares of the Issuer's common stock were converted into the right to receive $17.50 per share in cash, without interest.
- [F2]Immediately prior to the effective time of the merger between issuer and Stiefel Laboratories, Inc., all restrictions on these shares of restricted stock were released, and the shares became fully vested and eligible for the merger consideration in an amount equal to $17.50 multiplied by the number of shares of common stock subject to the restrictions, less any required witholding.
- [F3]Immediately prior to the effective time of the merger between issuer and Stiefel Laboratories, the options became fully vested. In exchange for the options, the Issuer paid to the Reporting Person either (a) -0- for each grant of options if the exercise price of the options was equal to or greater than the merger consideration of $17.50, or (b) an amount equal to the excess of the merger consideration ($17.50) over the exercise price multiplied by the number of shares of common stock subject to the option, less any required witholding, if the exercise price of the option was less than the merger consideration of $17.50.
- [F4]The stock options were granted under a Connetics Corporation stock option plan and, but for the merger between Issuer and Stiefel Laboratories, would have been exercisable at the rate of 25% on the one year anniversary and 1/48 per month thereafter.
- [F5]The stock options were granted under a Connetics Corporation stock option plan, and vested 100% on the first anniversary of the date of the grant.
Documents
Issuer
CONNETICS CORP
CIK 0001004960
Entity typeother
Related Parties
1- filerCIK 0001210526
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 8:31 PM ET
- Size
- 21.5 KB